On December 12, 2023, Delivra Health Brands Inc. closed the transaction. The Company issued a total of 60,000,000 Units at a price of CAD 0.015 per Unit for aggregate gross proceeds of CAD 900,000. Each Unit is comprised of one common share and one Common Share purchase warrant. Each Warrant will entitle the holder thereof to acquire one Common Share at a price of CAD 0.05 per Warrant Share for 36 months following the completion of the Offering. The transaction included participation from Certain insiders of the Company acquired an aggregate of 35,820,000 Units. In connection with the Offering, the Company incurred cash finder's fees of CAD 18,459 on gross proceeds raised by eligible arm's length parties.

The TSX Venture Exchange has accepted for filing documentation with respect to a non-brokered private placement. The transaction included participation from 8 placees including existing insider involvement of 6 insiders for 35,820,000 and pro group involvement of 2 pro groups for 24,180,000.